Pyrafat en es it fr

Pyrafat Brand names, Pyrafat Analogs

Pyrafat Brand Names Mixture

  • No information avaliable

Pyrafat Chemical_Formula

C43H51N3O11

Pyrafat RX_link

http://www.rxlist.com/cgi/generic/xifaxan.htm

Pyrafat fda sheet

Pyrafat FDA

Pyrafat msds (material safety sheet)

Pyrafat MSDS

Pyrafat Synthesis Reference

No information avaliable

Pyrafat Molecular Weight

785.879 g/mol

Pyrafat Melting Point

No information avaliable

Pyrafat H2O Solubility

No information avaliable

Pyrafat State

No information avaliable

Pyrafat LogP

4.161

Pyrafat Dosage Forms

No information avaliable

Pyrafat Indication

For the treatment of patients (>=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli.

Pyrafat Pharmacology

Rifaximin is a structural analog of rifampin and non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis. While an increase in pulmonary hydrogen excretion is evident in diverticular disease, the therapeutic effect of rifaximin does not appear to be due to a persistent correction of this alteration and the drug appears to cause no significant imbalance in the intestinal ecosystem.

Pyrafat Absorption

Low absorption in both the fasting state and when administered within 30 minutes of a high-fat breakfast.

Pyrafat side effects and Toxicity

LD50 > 2 g/kg (orally, in rats)

Pyrafat Patient Information

No information avaliable

Pyrafat Organisms Affected

Enteric bacteria and eubacteria